Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

Collection of Biospecimen and Clinical Information in Patients With Gastrointestinal Cancers

We have an active research program in gastrointestinal cancers including clinical trials, epidemiologic, and translational studies. We would like to establish a biospecimen bank linked to useful clinical information in order to learn more about diagnostic, predictive and prognostic markers for gastrointestinal cancers.

PRIMARY OBJECTIVES:

1. To collect and store tumor and normal tissue (previously collected paraffin embedded or frozen specimen) and blood in patients with gastrointestinal (GI) cancers.

SECONDARY OBJECTIVES:

1. Collect detailed clinical information via a patient questionnaire that includes demographic, socioeconomic, lifestyle, family, past medical, medication and cancer histories
2. Collect details about the tumor specimen extracted from patient charts.

Study Overview

• Status: Withdrawn
• Conditions: Gastrointestinal Neoplasms; Pancreatic Cancer; Anal Cancer; Colon/Rectal Cancer; Hepatobiliary Cancers; Gastric (Stomach) Cancer; Gynecologic Cancers; Gastro-Esophageal(GE) Junction Cancer; Gynecologic Cancers Cervical Cancer; Gastrointenstinal Stromal Tumor (GIST); Colon/Rectal Cancer Colon Cancer; Colon/Rectal Cancer Rectal Cancer; Colon/Rectal Cancer Anal Cancer; Hepatobiliary Cancers Liver
• Intervention / Treatment: Procedure: Blood Draw; Procedure: Frozen Tumor Specimens

• Study Type: Observational

Contacts and Locations

Study Locations

• United States
  • California
    • Stanford, California, United States, 94305
      • Stanford University School of Medicine

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients with gastrointestinal cancer.

Description

Inclusion Criteria:1. Patients are eligible if they have a histologically proven gastrointestinal cancer (esophageal, gastroesophageal junction, gastric, small intestine, appendix, colon, rectum, anus, liver, gallbladder, bile ducts, pancreas, neuroendocrine, and GI stromal tumor).

2. 18 years of age or older

3. Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria:None

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure
None: Biospecimen will be collected for future research.

Collaborators and Investigators

• Sponsor: Stanford University
• Collaborators: Caring for Carcinoid Foundation; GI Cancer Research Gift Fund
• Investigators: Principal Investigator: Teri A Longacre M.D., Stanford University

Study record dates

Study Major Dates

• Study Start: January 1, 2010
• Primary Completion (ANTICIPATED): January 1, 2099
• Study Completion (ANTICIPATED): January 1, 2099

Study Registration Dates

• First Submitted: December 10, 2009
• First Submitted That Met QC Criteria: December 11, 2009
• First Posted (ESTIMATE): December 14, 2009

Study Record Updates

• Last Update Posted (ESTIMATE): May 28, 2012
• Last Update Submitted That Met QC Criteria: May 24, 2012
• Last Verified: May 1, 2012

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Digestive System Diseases; Neoplasms; Neoplasms by Site; Gastrointestinal Diseases; Stomach Diseases; Colonic Diseases; Intestinal Diseases; Intestinal Neoplasms; Rectal Diseases; Anus Diseases; Stomach Neoplasms; Colorectal Neoplasms; Rectal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Anus Neoplasms
• Other Study ID Numbers: SU-09092009-3840; GI0004